Key facts
- Notable investors include Korea Investment Partners, Oxford University Innovation.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for NantWorks
- ·The full record, as it builds
Funding rounds
No funding rounds for NantWorks are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NantWorks
Operator of a research and development holding firm intended to operate a line of companies serving the biotech and healthcare sectors. The company's services focus on developing semiconductor technologies and an integrated fact-based, genomically-informed, personalized approach to the delivery of care and the development of next-generation diagnostics and therapeutics, enabling clients to develop and deliver a diverse range of technologies that accelerate innovation, broaden the scope of scientific discovery, enhance ground-breaking research, and improve healthcare treatment of those in need.
- Sector
- Healthcare
- HQ
- Culver City, CA, United States
- Founded
- 2007
- Employees
- 80
- Website
- nantworks.com/
- Ownership
- Privately Held (backing)
NantWorks doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NantWorks shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NantWorks in its N-PORT filings yet. We sweep new filings monthly.